IRIS
Valenti, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 583
EU - Europa 208
AS - Asia 206
AF - Africa 20
OC - Oceania 1
SA - Sud America 1
Totale 1.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 580
CN - Cina 96
SG - Singapore 96
IE - Irlanda 48
FI - Finlandia 44
FR - Francia 26
IT - Italia 25
NG - Nigeria 19
BE - Belgio 12
DE - Germania 12
SE - Svezia 10
GB - Regno Unito 7
IN - India 7
NL - Olanda 7
RU - Federazione Russa 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
JP - Giappone 4
MX - Messico 3
PT - Portogallo 2
AU - Australia 1
BR - Brasile 1
IM - Isola di Man 1
KR - Corea 1
KW - Kuwait 1
RS - Serbia 1
TN - Tunisia 1
TR - Turchia 1
Totale 1.019
Salva come PNG Salva come JPEG
Città #
Chandler 150
Shanghai 93
Singapore 72
Boardman 70
Dublin 48
Helsinki 44
New York 42
Wilmington 24
San Mateo 23
Lawrence 22
Princeton 22
Benin City 19
Ashburn 13
Paris 12
Brussels 11
Los Angeles 11
Seattle 10
Ann Arbor 9
Dallas 9
Milan 8
Duncan 7
Phoenix 7
Amsterdam 6
London 6
Santa Clara 5
Brno 4
Esbjerg 4
Moscow 4
Tokyo 4
Aguascalientes 3
Bergamo 3
Catania 3
Fairfield 3
Leawood 3
Munich 3
Pavia 3
Chengdu 2
Falkenstein 2
Kochi 2
Ludhiana 2
Nancy 2
Pune 2
Thyez 2
Andover 1
Belgrade 1
Berlin 1
Bollebygd 1
Chicago 1
Douglas 1
Dundee 1
Florence 1
Kocaeli 1
Kuwait City 1
Longueville 1
New Delhi 1
Newark 1
Norwalk 1
Novokuznetsk 1
Oakland 1
Redmond 1
Rome 1
Sale Marasino 1
San Diego 1
Tunis 1
Venlo 1
Totale 816
Salva come PNG Salva come JPEG
Nome #
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 83
Brodalumab: a new way to inhibit IL-17 in psoriasis 58
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 57
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever 43
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population 42
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab 36
Palmar nodules in a young woman with ulcerative colitis and enteropathic arthritis 34
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients 34
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study 34
Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology? 33
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 33
Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab 32
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study 32
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study 31
Urticarial rash in autoinflammatory syndromes 31
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab 29
Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital 25
Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis 18
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study 16
Cutaneous toxicity of CAR T-cell therapy: Case report of a bullous life-threatening reaction 15
Multiple facial angiofibromas: A manifestation of Frank-ter Haar syndrome? 14
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 13
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study 12
Skin cancers: how to balance the risks and benefits of surgery during COVID-19 pandemic (a Northern Italy single-center experience) 12
Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: Real-world experience from two Italian hospitals 12
Bullous vasculitis associated with Streptococcus pyogenes sepsis 11
Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy 11
Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience 11
Real-life efficacy of guselkumab in patients with early psoriatic arthritis 11
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy 11
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study 10
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma 10
Early predictors of psoriatic arthritis: a delphi based consensus from Italian dermatology centers 10
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis) 10
Efficacy and safety of switching psoriatic patients to bimekizumab: new evidence from clinical trials 10
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience 9
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study 9
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study 9
Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report 9
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 8
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks 7
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study 7
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab 7
A severe case of IgA bullous pemphigoid successfully treated with dupilumab 7
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers 7
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients 7
What Can IBD Specialists Learn from IL-23 Trials in Dermatology? 7
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case‐series 6
Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation 6
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? 6
Long-term management of pediatric psoriasis with ixekizumab: a case report 6
Risankizumab for the treatment of genital psoriasis: A 1-year, real-world experience 5
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 5
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study 5
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV-2 infection and vaccination 5
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience 5
Combination intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion 5
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study 5
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 5
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study 5
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series 5
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report 5
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 4
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study 4
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case report 4
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers 3
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patients 2
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals 2
Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment 2
How to integrate surgery and targeted therapy with biologics for the treatment of hidradenitis suppurativa: Delphi consensus statements from an Italian expert panel 2
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review 2
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options 2
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) 2
Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma 2
Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study 2
Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy 1
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features 1
Totale 1.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 2 0 0 0 8 6 8 13 7 1 11
2021/2022110 1 0 3 13 2 3 5 10 26 8 32 7
2022/2023359 55 28 25 58 33 27 0 29 55 29 20 0
2023/2024520 16 37 98 28 11 49 59 45 12 22 52 91
2024/202546 13 33 0 0 0 0 0 0 0 0 0 0
Totale 1.091